Danaher Corp. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Danaher Corp. (DHR) shares fell 1.51% to $199.58 on Tuesday, underperforming competitors like Thermo Fisher Scientific, Abbott Laboratories, and Medtronic amid a broader market decline. The stock closed 17.80% below its 52-week high of $242.80. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Danaher Corp. (DHR) slid 1.51% to $199.58 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
Danaher Corp. closed 17.80% below its 52-week high of $242.80, which the company reached on January 22nd.
The stock underperformed when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc. (TMO) rose 0.60% to $589.04, Abbott Laboratories (ABT) rose 2.09% to $112.68, and Medtronic PLC (MDT) rose 1.64% to $92.09.
Trading volume (2.3 M) remained 2.7 million below its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-18-26 1637ET